Tuesday, November 24, 2009, 3:32AM AEST - The Australian Stockmarket opens in 6 hours and 28 minutes.
To create a watchlist or portfolio of shares, Register

DUSA Pharmaceuticals Inc. (DUSA)

3:17AM AEST: 1.59 USD  Down 0.03 (1.85%)  
 MORE ON DUSA 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 DUSA Pharmaceuticals, Inc. (NGM:DUSA) Delayed quote dataEdit
Last Trade:1.59 USD
Trade Time: 3:17AM AEST
Change:Down 0.03 (1.85%)
Prev Close:1.62
Open:1.59
Bid:1.59 x 5000
Ask:1.62 x 300
1y Target Est:6.00
Day's Range:1.59 - 1.70
52wk Range:0.88 - 1.80
Volume:11,825
Avg Vol (3m):80,524.2
Market Cap:38.33M
P/E (ttm):N/A
EPS (ttm):-0.20
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add DUSA to Portfolio   Download Data

 HEADLINES 
DUSA PHARMACEUTICALS INC Financials
EDGAR Online Financials (Sat, Nov 14)
New Star Analyst Rankings for DUSA Pharmaceuticals, Inc.
StarMine (Wed, Nov 11)
DUSA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Nov 7)
DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
PR Newswire (Sat, Nov 7)
Q3 2009 DUSA Pharmaceuticals Earnings Release - 06:30 am ET
CCBN (Fri, Nov 6)
DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results
PR Newswire (Fri, Nov 6)
DUSA Pharmaceuticals, Inc.(R) Announces Third Quarter Financial Results and Corporate Highlights Conference Call
PR Newswire (Tue, Nov 3)
CEO Interview: Provectus Pharmaceuticals, Inc. - Peter R. Culpepper
Wall Street Transcript (Tue, Nov 3)
DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
PR Newswire (Wed, Oct 28)
DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America
PR Newswire (Wed, Oct 21)
More Headlines for DUSA...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.18
EPS Est (in 2 years) (Dec-10) :-0.07
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
DUSA Pharmaceuticals, Inc., an integrated dermatology pharmaceutical company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions in the United States and internationally.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices